RxDoctor Payments Data

Minh-Tri Nguyen, MD

Transplant Surgery · San Bernardino, CANPI 1679940076

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (45.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 69.9% of it on its own, with 13 other manufacturers making up the rest.

$7,720in general payments, 2019–2025

Across 52 payments — averaging $148.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$5K
  • Johnson & Johnson$883
  • Veloxis Pharmaceuticals, Inc.$267
  • E.r. Squibb & Sons, L.L.C.$202
  • Mallinckrodt Hospital Products Inc.$185
  • Baxter Healthcare$178
  • plus $609 from 8 others

What the payments were for

  • Travel & lodging$1,77123%
  • Food & beverage$2,44932%
  • Education$3,50045%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,720 in reported general payments places this provider in the 80th percentile of 56 transplant surgery providers in California.

See all transplant surgery providers in California

Medicare billing

Part B allowed, 2024
$99,766
Medicare patients
70
Services billed
260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Valganciclovir Hcl170$23,017
LokelmaSodium Zirconium Cyclosilicate20$21,634
Humalog Kwikpen U-100Insulin Lispro25$3,820
Ultra-Fine Nano Pen NeedlePen Needle, Diabetic53$3,473
Insulin Lispro Kwikpen U-100Insulin Lispro21$3,294
Clotrimazole59$2,550
Fluconazole55$2,203
Novolog FlexpenInsulin Aspart12$1,565
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,274
Nifedipine ErNifedipine51$1,104
Nano 2nd Gen Pen NeedlePen Needle, Diabetic24$1,104
Tacrolimus12$1,033
Mycophenolate Mofetil26$866
Unifine PentipsPen Needle, Diabetic23$735
Famotidine126$620

Paid to pharmacies, not to this prescriber.

Other transplant surgery in San Bernardino

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →